Clinical Trial Update: Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating enzalutamide in combination with relacorilant for prostate cancer has completed. The document summarizes the trial status an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Relacorilant (relacorilant)

Snippet

Sponsor: University of Chicago | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED